DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

Cytokinetics, Inc. (NASDAQ: CYTK)

4.67 0.08 (1.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTK $4.67 1.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.58
Previous Close $4.59
Daily Range $4.58 - $4.98
52-Week Range $3.05 - $13.26
Market Cap $171.0M
P/E Ratio -12.41
Dividend (Yield) $0.00 (0.0%)
Volume 469,110
Average Daily Volume 321,068
Current FY EPS -$0.96

Sector

Healthcare

Industry

Drugs

Cytokinetics, Inc. (CYTK) Description

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer. Website: http://www.cytokinetics.com/

News & Commentary Rss Feed

Biotech 101: Valuing Binary Events

Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.

Can the Rally in Cytokinetics (CYTK) Shares Continue? - Tale of the Tape

Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog

Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog

Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog

Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog

3 Stocks to Buy With Your Bull Market Profits

Dynavax's Heplisav Phase III Trial Recommended to Continue - Analyst Blog

Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog

Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog

Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog

Sarepta Q3 Loss Narrower-Than-Expected, Eteplirsen in Focus - Analyst Blog

Medivation Q3 Earnings, Revenues Lag Estimates - Analyst Blog

Medivation Q3 Earnings, Revenues Lag Estimates - Analyst Blog

See More CYTK News...

CYTK's Top Competitors

CYTK $4.67 (1.74%)
Current stock: CYTK
AMGN $165.31 (0.36%)
Current stock: AMGN
GILD $100.20 (-0.10%)
Current stock: GILD
BIIB $307.62 (0.89%)
Current stock: BIIB